Pattnaik, AryamavDhalech, Adeeba H.Condotta, Stephanie A.Corn, CalebRicher, Martin J.Snell, Laura M.Robinson, Christopher M.2024-05-232024-05-232024-01-11Pattnaik A, Dhalech AH, Condotta SA, et al. A viral-specific CD4+ T cell response protects female mice from Coxsackievirus B3 infection. Front Immunol. 2024;14:1327384. Published 2024 Jan 11. doi:10.3389/fimmu.2023.1327384https://hdl.handle.net/1805/40960Background: Biological sex plays an integral role in the immune response to various pathogens. The underlying basis for these sex differences is still not well defined. Here, we show that Coxsackievirus B3 (CVB3) induces a viral-specific CD4+ T cell response that can protect female mice from mortality. Methods: We inoculated C57BL/6 Ifnar-/- mice with CVB3. We investigated the T cell response in the spleen and mesenteric lymph nodes in male and female mice following infection. Results: We found that CVB3 can induce expansion of CD62Llo CD4+ T cells in the mesenteric lymph node and spleen of female but not male mice as early as 5 days post-inoculation, indicative of activation. Using a recombinant CVB3 virus expressing a model CD4+ T cell epitope, we found that this response is due to viral antigen and not bystander activation. Finally, the depletion of CD4+ T cells before infection increased mortality in female mice, indicating that CD4+ T cells play a protective role against CVB3 in our model. Conclusions: Overall, these data demonstrated that CVB3 can induce an early CD4 response in female but not male mice and further emphasize how sex differences in immune responses to pathogens affect disease.en-USAttribution 4.0 InternationalCoxsackievirus B3Enteric virusCD4 T cellsT cellsViral clearanceSex differencesArticle